Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-30

Clinical Trial Update: Assessment of DHA On Reducing Early Preterm Birth [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing whether DHA reduces early preterm birth has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Preterm Birth | Phase 3 | Status: COMPLETED